13 studies found for:    "Coal workers pneumoconiosis"
Show Display Options
Rank Status Study
1 Completed Specialized Center of Research in Occupational and Immunologic Lung Disease
Conditions: Lung Diseases, Obstructive;   Asbestosis;   Silicosis;   Pneumoconiosis;   Chronic Obstructive Pulmonary Disease
Intervention:
2 Unknown  Assessment of Iron Deposition in Major Organs of Hemodialysis Patients
Condition: Iron Overload
Intervention:
3 Completed Identifying Shared Genetic Susceptibility Regions in Chronic Beryllium Disease and Sarcoidosis
Conditions: Sarcoidosis;   Berylliosis
Intervention:
4 Recruiting Superficial Siderosis in Patients With Suspected Cerebral Amyloid Angiopathy
Conditions: Intracerebral Hemorrhage;   Cerebral Amyloid Angiopathy;   Ischemic Stroke
Intervention:
5 Unknown  DNA-damage Pathways in Workers Exposed to Silica (Caesar Stone)
Condition: Silicosis
Intervention:
6 Recruiting Oscillation Mechanics of the Respiratory System in Never-smoking Patients With Silicosis
Condition: Silicosis
Intervention:
7 Completed fMRI of the Brainstem in Migraine Sufferers and Controls. Does Iron Deposition Correlate With Progression of Disease?
Conditions: Episodic Migraine;   Chronic Daily Migraine
Intervention:
8 Active, not recruiting Observational Study of Deferiprone (Ferriprox®) in the Treatment of Superficial Siderosis
Condition: Superficial Siderosis
Intervention:
9 Unknown  Safety of Stem Cells Intrabronchial Instillation for Silicosis
Condition: Chronic and Accelerated Silicosis, Characterized With a Fibrotic Increase in the Last Two Years
Intervention: Other: Autologous cell transplantation
10 Unknown  Oxidative Stress Biomarkers to Monitor and Early Detect Health Impairment in Workers Exposed to Silica (Caesar Stone)
Condition: Silicosis
Intervention:
11 Completed Safety Study of Autologous Bone Marrow Stromal Cells With Modification by Hepatocyte Growth Factor to Treat Silicosis
Condition: Silicosis
Intervention: Other: Cells
12 Terminated
Has Results
Beryllium Infliximab Study: Clinical Interventional Trial
Conditions: Berylliosis;   Beryllium Disease
Intervention: Drug: Infliximab
13 Recruiting Targeting Oxidative Stress in Chronic Beryllium Disease
Condition: Chronic Beryllium Disease
Interventions: Drug: Mesalamine;   Drug: Placebo

Indicates status has not been verified in more than two years